Haematology-Oncology · Pathway 39
Myelofibrosis
Key points
- a myeloproliferative disorder
- thought to be caused by hyperplasia of abnormal megakaryocytes
- the resultant release of platelet derived growth factor is thought to stimulate fibroblasts
- haematopoiesis develops in the liver and spleen Features
- e.g. elderly person with symptoms of anaemia e.g. fatigue (the most common presenting symptom)